Table 4 Clinical features of clear cell tumors compared to Type I tumors, Type II tumors and Type I and II tumors in one group
| Â | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
|---|---|---|---|---|---|---|
| Â | 16 (29) | 40 (61) | 16 (18) | 75 (82) | 16 (12) | 115 (88) |
| Â | Clear cell | Type I | Clear cell | Type II | Clear cell | Other (Type I+II) |
| Â | Tumors | Tumors | Tumors | Tumors | Tumors | Tumors |
Age | 54.7 | 57.2 | 54.7 | 60.2 | 54.7 | 59.1 |
| Â | p = 0.388 | Â | p = 0.046 | Â | p = 0.100 | (t-test) |
BMI ≤ 25 | 11 (73) | 11 (36) | 11 (73) | 44 (61) | 11 (73) | 58 (52) |
BMI > 25 | 4 (27) | 25 (64) | 4 (27) | 28 (39) | 4 (27) | 53 (48) |
| Â | p = 0.013 | Â | p = 0.372 | Â | p = 0.123 | (chi-2) |
STAGE | Â | Â | Â | Â | Â | Â |
IA-B | 3 (19) | 20 (50) | 3 (19) | 22 (29) | 3 (19) | 42 (19) |
IC | 10 (62) | 16 (40) | 10 (62) | 40 (54) | 10 (62) | 56 (49) |
II | 3 (19) | 4 (10) | 3 (19) | 13 (17) | 3 (19) | 17 (15) |
| Â | p = 0.097 | Â | p = 0.669 | Â | p = 0.341 | (chi-2) |
Capsule | Â | Â | Â | Â | Â | Â |
Rupture* | Â | Â | Â | Â | Â | Â |
Yes | 10 (63) | 13 (33) | 10 (63) | 39(34) | 10 (63) | 26 (35) |
No | 6 (37) | 27 (67) | 6 (37) | 76 (66) | 6 (37) | 49 (65) |
| Â | p = 0.039 | Â | p = 0.027 | Â | p = 0.039 | (chi-2) |
Recurrence | Â | Â | Â | Â | Â | Â |
Without | 12 (75) | 31 (77) | 12 (75) | 54 (69) | 12 (75) | 85 (74) |
With | 4 (25) | 9 (23) | 4 (25) | 21 (31) | 4 (25) | 30 (26) |
| Â | p = 0.841 | Â | p = 0.807 | Â | p = 0.926 | (chi-2) |